Ligand Reports First Quarter 2024 Financial ResultsLigand Pharmaceuticals Incorporated (Nasdaq: LGND) today reported financial results for the three months ended March 31, 2024, and provided an operating forecast and business updates. Ligand...
Business Wire•3 months ago